Vivos Therapeutics, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Littleton, CO
VVOS chart
What traders are saying about $VVOS
Latest postsVivos Therapeutics, Inc. news
- Form 4 Vivos Therapeutics Inc: Mark F. Lindsay (Director) For: 14 September
Investing.com Canada ·
- Half vested immediately as Vivos Therapeutics (VVOS) granted a director 12,000 stock options.
Stock Titan ·
- Vivos Therapeutics, Inc. Estimates – NASDAQ:VVOS
TradingView ·
- Form 8K Vivos Therapeutics Inc For: 21 October By Investing.com
Investing.com Nigeria ·
- Vivos Therapeutics reports Nasdaq compliance confirmation with continued listing shareholders’ equity standard
TradingView ·
- Vivos Therapeutics confirms Nasdaq compliance with $2.5M stockholders’ equity after SOD transaction
TradingView ·
- Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
Yahoo Finance ·
- Vivos Therapeutics confirms Nasdaq compliance w...
Pluang ·
- SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
Yahoo Finance ·
- Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test
medicaldevice-network.com ·
Vivos Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $17.4M | $15.0M | $13.8M | $16.0M |
| Net income | -$21.2M | -$11.1M | -$13.6M | -$23.8M |
| Diluted EPS | $-2.07 | $-2.22 | $-11.14 | $-25.90 |
| Total assets (year end) | $25.2M | $15.3M | $10.7M | $13.7M |
| Cash and equivalents (year end) | $2.0M | $6.3M | $1.6M | $3.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vivos Therapeutics, Inc.
- Ticker
- VVOS (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Littleton, CO
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1716166
- Former names
- Vivos BioTechnologies, Inc.
Frequently asked questions
What exchange is Vivos Therapeutics, Inc. listed on?
Vivos Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VVOS.
What industry is Vivos Therapeutics, Inc. in?
Vivos Therapeutics, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Vivos Therapeutics, Inc. headquartered?
Vivos Therapeutics, Inc.'s business address on file with the SEC is in Littleton, CO.
When does Vivos Therapeutics, Inc.'s fiscal year end?
Vivos Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Vivos Therapeutics, Inc. report?
Vivos Therapeutics, Inc. reported $17.4M in revenue for calendar year 2025, according to its SEC filings.